Thieme E-Books & E-Journals -
Back
Thromb Haemost 2016; 116(05): 975-986
DOI: 10.1160/TH16-05-0403
Stroke, Systemic or Venous Thromboembolism
Schattauer GmbH

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

A propensity score matched analysis
Gregory Y. H. Lip
1   University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK
2   Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
Allison Keshishian
3   STATinMED Research, Ann Arbor, Michigan, USA
,
Shital Kamble
4   Bristol-Myers Squibb Company, Princeton, New Jersey, USA
,
Xianying Pan
4   Bristol-Myers Squibb Company, Princeton, New Jersey, USA
,
Jack Mardekian
5   Pfizer, Inc., New York, New York, USA
,
Ruslan Horblyuk
5   Pfizer, Inc., New York, New York, USA
,
Melissa Hamilton
4   Bristol-Myers Squibb Company, Princeton, New Jersey, USA
› Author Affiliations